Wordt geladen...
Implementing tumor mutational burden (TMB) analysis in routine diagnostics—a primer for molecular pathologists and clinicians
Tumor mutational burden (TMB) is a new biomarker for prediction of response to PD-(L)1 treatment. Comprehensive sequencing approaches (i.e., whole exome and whole genome sequencing) are ideally suited to measure TMB directly. However, as their applicability in routine diagnostics is currently limite...
Bewaard in:
| Gepubliceerd in: | Transl Lung Cancer Res |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
AME Publishing Company
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6249620/ https://ncbi.nlm.nih.gov/pubmed/30505715 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2018.08.14 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|